Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
React Bone+ is a multi-ingredient oral supplement developed by RH-Pharma, designed to support bone health and mineral density. The formulation typically combines calcium citrate, cholecalciferol (Vitamin D3), magnesium hydroxide, and zinc sulfate. Calcium serves as a fundamental structural element of the bone matrix, while Vitamin D3 acts as an agonist at the Vitamin D receptor (VDR) to enhance intestinal calcium absorption and maintain serum calcium homeostasis. Magnesium and zinc are included as essential cofactors for alkaline phosphatase activity and collagen synthesis, respectively, which are critical for bone mineralization and remodeling. This product is primarily used for the management of calcium and vitamin D deficiencies, osteopenia, and as supportive therapy in osteoporosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on React Bone+.